Source: International Congress 2018 – Functional genomics and COPD: new challenges
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. lkhagvadorj (Groningen, Netherlands), K. F. Meyer (Groningen, Netherlands), L. P. Verweij (Groningen, Netherlands), Z. Zeng (Groningen, Netherlands), T. Plösch (Groningen, Netherlands), M. Hylkema (Groningen, Netherlands). Cytochrome P450 2A5 methylation and gene expression profile is organ-specific and affected by maternal smoking during pregnancy. 938

Member's Comments

No comment yet.

Related content which might interest you: Expression of xenobiotic-metabolizing enzymes in human pulmonary tissue: possible role in susceptibility for ILD Source: Eur Respir J 2001; 18: 122S-126S Year: 2001 The perpetrator potential of sitaxentan based on its ability to inhibit human cytochrome P450 (CYP) enzymes Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous Year: 2008 Association analysis between polymorphisms in the cytochrome P450 2J2, 2S1 and UDP-glucuronosyltransferase 2B7 genes with occupational chronic bronchitis Source: Annual Congress 2010 - Genetics of obstruction Year: 2010 Cytochrome P450 1A1 polymorphism and severity of COPD Source: Eur Respir J 2002; 20: Suppl. 38, 212s Year: 2002 Effects of aryl hydrocarbon receptor and cytochrome P450 1A1 polymorphisms on childhood lung function and asthma Source: Eur Respir J 2007; 30: Suppl. 51, 296s Year: 2007 Absence of inhibitory effect of levocetirizine on the metabolism of human cytochrome P450 model substrates Source: Eur Respir J 2005; 26: Suppl. 49, 136s Year: 2005 Interaction of GSTMI null variant and cytochrome P-450 type 1A1 Ile462Val polymorphism and susceptibility to COPD Source: Eur Respir J 2002; 20: Suppl. 38, 94s Year: 2002 Cytochrome P450 pharmacogenetics: a possible predictor of pulmonary drug induced toxicity? Source: Eur Respir J 2007; 30: Suppl. 51, 488s Year: 2007 The perpetrator potential of sitaxentan: human CYP enzyme induction Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous Year: 2008 Genetic association study of CYP1A1 polymorphisms identifies risk haplotypes in nonsmall cell lung cancer Source: Eur Respir J 2010; 35: 152-159 Year: 2010 CYP1A1, CYP1A2, CYP1B1, CYP2E1 polymorphisms and the risk of occupational chronic bronchitis Source: Annual Congress 2008 - Advances in functional genomics of neoplastic and non-neoplastic lung diseases Year: 2008 Association of polymorphisms of cytochrome P450 genes (CYP1A1 and CYP1A2) with chronic obstructive pulmonary disease in Tatars and Russians from Bashkortostan Source: Eur Respir J 2007; 30: Suppl. 51, 21s Year: 2007 Genetic polymorphisms in the cytochromes P450, microsomal epoxide hydrolase and glutathione S-transferase M1, T1 and P1 genes and their relationship to relapsing bronchitis and pneumonia in case of children Source: Eur Respir J 2005; 26: Suppl. 49, 167s Year: 2005 Influence of allele variants of CYP2A6 and NAT2 genes on features of phenotype of tobacco smoker Source: Eur Respir J 2004; 24: Suppl. 48, 503s Year: 2004 Common variants of the microsomal epoxide hydrolase and glutamate-cysteine ligase in European populations are not associated with susceptibility to COPD Source: Annual Congress 2008 - Advances in functional genomics of neoplastic and non-neoplastic lung diseases Year: 2008 The victim potential of sitaxentan: metabolism by human CYP450 enzymes Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous Year: 2008 Reversible inhibition of mitochondrial complex IV activity in PBMC following acute smoking Source: Eur Respir J 2004; 23: 214-218 Year: 2004 Interactions between roflumilast and cytochrome P450 inducers and inhibitors: Overview of existing studies Source: Annual Congress 2010 - Management of airway disease Year: 2010 N-acetyltransferase 2 and CYP2E1 polymorphisms do not increase the risk of antituberculosis drug-induced hepatotoxicity in caucasian population Source: Annual Congress 2008 - Epidemiological and clinical aspects of tuberculosis control Year: 2008